Osteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage. A whopping 8.9 million fractures are caused by osteoporosis annually, with one fracture occurring every three seconds.
Study reveals promising drug target for treating osteoporosis retrieved 18 June 2024 from https://medicalxpress.com/news/2024-06-reveals-drug-osteoporosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New study reveals key protein that could help prevent excessive bone loss in osteoporosisOsteoporosis, a condition characterized by porous and fragile bones, poses a significant threat to skeletal health. As the very framework of the human body, bones provide crucial structural support. When bone mass diminishes, it not only compromises this support but also impairs overall function, leading to a diminished quality of life.
Read more »
Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the Basque Country (UPV/EHU) and researchers from the CIBER of Mental Health (CIBERSAM), and published in Nature Communications, may facilitate the creation of new personalized...
Read more »
Gprc5a identified as potential drug target for treating osteoporosisOsteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage.
Read more »
Can we withdraw treatment in post-menopausal osteoporosis?Bisphosphonates are the recommended first-line treatment in post-menopausal osteoporosis, with denosumab recommended second-line.
Read more »
USPSTF recommends osteoporosis screening for women aged 65 years and olderThe U.S. Preventive Services Task Force (USPSTF) recommends screening for osteoporosis for women aged 65 years and older and for postmenopausal women younger than 65 years with one or more risk factors. These recommendations form the basis of a draft recommendation statement published online June 11.
Read more »
Colon cancers are rising among the young: New study outlines the warning signsColon cancer is increasingly hitting Americans under the age of 50, and a new study outlines the warning signs that these young patients first encounter.
Read more »